Liza Logounova - JelikaLite

JelikaLite has been awarded Technology Enhancement for Commercial Partnerships (TECP) grant from the NSF

JelikaLite has been awarded Technology Enhancement for Commercial Partnerships (TECP) grant from the NSF

Products
Science
Autism
Company
Press & News

linkedin

Sign up for Early Access

December 7, 2021

Liza Logounova

Learn More

Post navigation

Previous: Luis DeTaboada, MS

Next: Eugenia Steingold, PhD

Search for:

Recent Posts

JelikaLite Inc. has been awarded a $189,000 Technology Enhancement for Commercial Partnerships (TECP) grant from the U.S. National Science Foundation (NSF)
We’re thrilled to share a significant achievement for JelikaLite. Our groundbreaking study, “Transcranial photobiomodulation for reducing symptoms of autism spectrum disorder and modulating brain electrophysiology in children aged 2–7: an open label study” has been published in Frontiers in Child and Adolescent Psychiatry 📚.
JelikaLite has been awarded a 2-year, $959,000 National Science Foundation (NSF) grant to develop a non-invasive therapeutic brain stimulation medical device to improve the communication, responsiveness, and social integration of autistic children. The project’s objectives are to finalize the current clinical prototype into a manufacturing-ready product and implement a platform for personalizing transcranial photobiomodulation (tPBM) treatment based on individual sensor -derived patient characteristics. Results could enrich scientific knowledge through personalization, monitoring, and data aggregation of neurological measures for further elucidating the mechanisms of autism and enhancing the efficacy of other therapies. Read more here https://lnkd.in/e23Yj74y.
We’re thrilled to share a significant achievement for JelikaLite. Our groundbreaking study, “Transcranial Photobiomodulation in Children Aged 2–6 Years: A Randomized Sham-Controlled Clinical Trial Assessing Safety, Efficacy, and Impact on Autism Spectrum Disorder Symptoms and Brain Electrophysiology,” has been published in Frontiers in Neurology 📚.
JelikaLite participated in Floreo VR’s inaugural virtual roundtable. A technology innovations such as Virtual Reality and wearables have begun to transform the delivery of behavioral therapy and developmental services for neurodiverse populations. Evidence demonstrates high levels of engagement among learners and the potential for improved outcomes. This panel discussed key trends, implications for therapy providers, what’s needed for further adoption, and the promise of these technologies.

Recent Comments

Archives

April 2026
January 2025
September 2024
May 2024
November 2023
May 2023
February 2023
January 2023
April 2022
January 2022
December 2021
October 2021
August 2021
June 2021
March 2021

Categories

Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

Company

Products
Science
Autism
Company
Press & News

Rules

Disclaimer
Privacy Policy

Social

linkedin

Copyright ©2026 jelikalite. All rights reserved.